ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
tonks306511
|
1.0K |
299K |
2 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
1.0K
|
299K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
tonks306511
|
364 |
132K |
2 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
364
|
132K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
tonks306511
|
364 |
132K |
10 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
364
|
132K
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Phase III CLARIFY trial in prostate cancer commences
|
|
tonks306511
|
14 |
4.8K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
14
|
4.8K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
21K
|
7.4M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
0 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
21K
|
7.4M
|
0
|
|
ASX - By Stock
|
PH2 |
Re:
Ann: North American order for HFCE vehicles
|
|
tonks306511
|
20 |
8.0K |
2 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
20
|
8.0K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: SECuRE theranostic prostate cancer trial progresses
|
|
tonks306511
|
8 |
2.5K |
16 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
8
|
2.5K
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: SECuRE theranostic prostate cancer trial progresses
|
|
tonks306511
|
8 |
2.5K |
20 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
8
|
2.5K
|
20
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: 2023 AGM Chair's Address to Shareholders
|
|
tonks306511
|
19 |
5.9K |
6 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
19
|
5.9K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
tonks306511
|
508 |
127K |
14 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
127K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
tonks306511
|
508 |
127K |
18 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
508
|
127K
|
18
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
tonks306511
|
364 |
132K |
4 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
364
|
132K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
tonks306511
|
231 |
68K |
17 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
68K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
tonks306511
|
101 |
21K |
4 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
101
|
21K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
3 |
08/11/23 |
08/11/23 |
General
|
11K
|
3.8M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
21K
|
7.4M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
tonks306511
|
62 |
21K |
8 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
62
|
21K
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
1 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
21K
|
7.4M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Annual Report to Shareholders
|
|
tonks306511
|
9 |
4.4K |
9 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
9
|
4.4K
|
9
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
34 |
02/11/23 |
02/11/23 |
General
|
11K
|
3.8M
|
34
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
2 |
02/11/23 |
02/11/23 |
General
|
11K
|
3.8M
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
4 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
21K
|
7.4M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
tonks306511
|
96 |
26K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
96
|
26K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
58 |
25/10/23 |
25/10/23 |
General
|
11K
|
3.8M
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
tonks306511
|
2.9K |
1.0M |
5 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
2.9K
|
1.0M
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
11 |
12/10/23 |
12/10/23 |
General
|
11K
|
3.8M
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Date of AGM and Closing Date for Director Nominations
|
|
tonks306511
|
71 |
21K |
5 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
71
|
21K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
|
|
tonks306511
|
218 |
73K |
25 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
218
|
73K
|
25
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Change in substantial holding
|
|
tonks306511
|
4 |
1.2K |
4 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
4
|
1.2K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
tonks306511
|
450 |
149K |
21 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
450
|
149K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
tonks306511
|
450 |
149K |
22 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
450
|
149K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
tonks306511
|
450 |
149K |
7 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
450
|
149K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
29 |
21/08/23 |
21/08/23 |
General
|
11K
|
3.8M
|
29
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
21K
|
7.4M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
15 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
21K
|
7.4M
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
5 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
21K
|
7.4M
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity Bolsters Antibody Pre-Targeting with IP from MSK
|
|
tonks306511
|
40 |
10K |
4 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
40
|
10K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
7 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
21K
|
7.4M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
tonks306511
|
35 |
13K |
14 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
35
|
13K
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
11K |
3.8M |
7 |
26/07/23 |
26/07/23 |
General
|
11K
|
3.8M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene AML trial in Israel advances to Phase 2
|
|
tonks306511
|
233 |
83K |
16 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
233
|
83K
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
5 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
21K
|
7.4M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
8 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
21K
|
7.4M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race executes agreement with Ardena for GMP manufacturing
|
|
tonks306511
|
35 |
14K |
2 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: H1 2023 Preclinical and Clinical Programs Update
|
|
tonks306511
|
119 |
42K |
4 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
119
|
42K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race global agreement with City of Hope to access FTO IP
|
|
tonks306511
|
268 |
83K |
14 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
268
|
83K
|
14
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial
|
|
tonks306511
|
55 |
15K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
55
|
15K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Ceasing to be a substantial holder
|
|
tonks306511
|
22 |
5.9K |
2 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
22
|
5.9K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
21K |
7.4M |
1 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
21K
|
7.4M
|
1
|
|